Leszek Tylicki

1.7k total citations
86 papers, 1.2k citations indexed

About

Leszek Tylicki is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Infectious Diseases. According to data from OpenAlex, Leszek Tylicki has authored 86 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 26 papers in Nephrology and 16 papers in Infectious Diseases. Recurrent topics in Leszek Tylicki's work include Blood Pressure and Hypertension Studies (19 papers), Renin-Angiotensin System Studies (17 papers) and Chronic Kidney Disease and Diabetes (16 papers). Leszek Tylicki is often cited by papers focused on Blood Pressure and Hypertension Studies (19 papers), Renin-Angiotensin System Studies (17 papers) and Chronic Kidney Disease and Diabetes (16 papers). Leszek Tylicki collaborates with scholars based in Poland, Austria and United States. Leszek Tylicki's co-authors include Piotr Rutkowski, Marcin Renke, Przemysław Rutkowski, Bogdan Biedunkiewicz, Alicja Dębska‐Ślizień, Ewa Aleksandrowicz, Wiesława Łysiak−Szydłowska, Sławomir Lizakowski, Walter H. Hörl and Andrzej Chamienia and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and American Journal of Kidney Diseases.

In The Last Decade

Leszek Tylicki

82 papers receiving 1.1k citations

Peers

Leszek Tylicki
Marcin Renke Poland
Wonngarm Kittanamongkolchai United States
Mads Hornum Denmark
G Keusch Switzerland
Juan Carlos Q. Velez United States
Gursharan Dogra Australia
Kenechukwu Mezue United States
Amy K. Mottl United States
Th. Philipp Germany
María Jesús Puchades Spain
Marcin Renke Poland
Leszek Tylicki
Citations per year, relative to Leszek Tylicki Leszek Tylicki (= 1×) peers Marcin Renke

Countries citing papers authored by Leszek Tylicki

Since Specialization
Citations

This map shows the geographic impact of Leszek Tylicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leszek Tylicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leszek Tylicki more than expected).

Fields of papers citing papers by Leszek Tylicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leszek Tylicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leszek Tylicki. The network helps show where Leszek Tylicki may publish in the future.

Co-authorship network of co-authors of Leszek Tylicki

This figure shows the co-authorship network connecting the top 25 collaborators of Leszek Tylicki. A scholar is included among the top collaborators of Leszek Tylicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leszek Tylicki. Leszek Tylicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zakrzewska, Agnieszka, et al.. (2025). Plasmapheresis for Suspected Drug-Induced Liver Injury During Pregnancy: A Multidisciplinary Diagnostic and Therapeutic Challenge. Journal of Clinical Medicine. 14(23). 8385–8385.
2.
3.
Zakrzewska, Agnieszka, Magdalena Jankowska, Bogdan Biedunkiewicz, et al.. (2024). Intradialytic Tolerance and Recovery Time in Different High-Efficiency Hemodialysis Modalities. Journal of Clinical Medicine. 13(2). 326–326. 2 indexed citations
4.
Zakrzewska, Agnieszka, Bogdan Biedunkiewicz, Sylwia Małgorzewicz, et al.. (2024). The Efficacy and Safety of High-Dose Cholecalciferol Therapy in Hemodialysis Patients. Biomedicines. 12(2). 377–377. 1 indexed citations
5.
Ruszkowski, Jakub, Zbigniew Heleniak, Aleksandra Parczewska, et al.. (2023). Effect of COVID-19 on Kidney Graft Function One Year after Onset. Medicina. 60(1). 26–26. 3 indexed citations
6.
Stompór, Tomasz, Marcin Adamczak, Ilona Kurnatowska, et al.. (2023). Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology. Journal of Clinical Medicine. 12(16). 5184–5184. 3 indexed citations
7.
Heleniak, Zbigniew, Maciej Głyda, Sławomir Lizakowski, et al.. (2022). Short-term Effects of Losartan on Cardiovascular Risk and Allograft Injury Biomarkers in Kidney Transplant Recipients. Transplantation Proceedings. 54(4). 981–988. 4 indexed citations
8.
9.
Zakrzewska, Agnieszka, et al.. (2018). Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor. Transplantation Proceedings. 50(6). 1838–1841. 1 indexed citations
10.
Tylicki, Leszek, Zbigniew Heleniak, Hanna Garnier, et al.. (2018). Improvement of Blood Pressure Control in Renal Transplant Recipients—Retrospective Longitudinal Study. Transplantation Proceedings. 50(1). 155–159. 3 indexed citations
11.
Tylicki, Leszek, Zbigniew Heleniak, Hanna Garnier, et al.. (2018). Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses. Kidney & Blood Pressure Research. 43(1). 45–54. 12 indexed citations
12.
Heleniak, Zbigniew, et al.. (2016). Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease. Journal of Nephrology. 30(6). 781–786. 22 indexed citations
13.
Tylicki, Leszek, et al.. (2014). Treatment of hypertension in chronic kidney disease patients under specialized care: One-center cross-sectional analyses. Blood Pressure. 24(2). 79–85. 6 indexed citations
14.
Renke, Marcin, Sławomir Lizakowski, Leszek Tylicki, et al.. (2014). Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study. Advances in Medical Sciences. 59(2). 256–260. 12 indexed citations
15.
Lizakowski, Sławomir, Leszek Tylicki, Przemysław Rutkowski, et al.. (2013). Safety of enhanced renin–angiotensin–aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease. Polskie Archiwum Medycyny Wewnętrznej. 123(5). 221–227. 5 indexed citations
16.
Tylicki, Leszek, Sławomir Lizakowski, Przemysław Rutkowski, et al.. (2012). The Enhanced Renin-Angiotensin-Aldosteron System Pharmacological Blockade - Which is the Best?. Kidney & Blood Pressure Research. 36(1). 335–343. 18 indexed citations
17.
Lizakowski, Sławomir & Leszek Tylicki. (2011). Aliskiren — nowe możliwości nefroprotekcji?. 4(2). 153–160.
18.
Tylicki, Leszek, et al.. (2006). Randomized Placebo-Controlled Study on the Effects of Losartan and Carvedilol on Albuminuria in Renal Transplant Recipients. Transplantation. 81(1). 52–56. 26 indexed citations
19.
Tylicki, Leszek, Sławomir Lizakowski, Bogdan Biedunkiewicz, et al.. (2004). Platelet function unaffected by ozonated autohaemotherapy in chronically haemodialysed patients. Blood Coagulation & Fibrinolysis. 15(7). 619–622. 6 indexed citations
20.
Tylicki, Leszek, Marcin Renke, Przemysław Rutkowski, & Piotr Rutkowski. (2002). Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: Pilot study. Journal of Renal Nutrition. 12(2). 122–125. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcin Renke Breakdown of academic impact, for papers by Wonngarm Kittanamongkolchai Breakdown of academic impact, for papers by Mads Hornum Breakdown of academic impact, for papers by G Keusch Breakdown of academic impact, for papers by Juan Carlos Q. Velez Breakdown of academic impact, for papers by Gursharan Dogra Breakdown of academic impact, for papers by Kenechukwu Mezue Breakdown of academic impact, for papers by Amy K. Mottl Breakdown of academic impact, for papers by Th. Philipp Breakdown of academic impact, for papers by María Jesús Puchades
Rankless by CCL
2026